KFDA to set fast review standards for new BT products.

To expedite rapid commercialization of the bio drugs, the health regulatory agency is going to establish a review standard and a supporting system, which may guide for the BT R&D to see its direction far in advance or aid for the BT researchers to monitor the research progress in advance through the DB.

The KFDA biomedical division unveiled the above supporting project as a taylor made admi...